| 12187721 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Mohamed S. A. Elsayed, Jay Bradford Fell +6 more |
2025-01-07 |
|
| 11998545 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Julia Haas +9 more |
2024-06-04 |
|
| 11884664 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Mohamed S. A. Elsayed, Jay Bradford Fell +7 more |
2024-01-30 |
|
| 11807651 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2023-11-07 |
|
| 11780835 |
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases |
Ronald Jay Hinklin, Shelley Allen, Patrick Barbour, Joshua Ryan Dahlke, John Gaudino +3 more |
2023-10-10 |
|
| 11648243 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more |
2023-05-16 |
|
| 11634417 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Mohamed S. A. Elsayed, Jay Bradford Fell +7 more |
2023-04-25 |
|
| 11634409 |
Compounds for the treatment of BRAF-associated diseases and disorders |
Patrick Barbour, Katie Keaton BROWN, Erik James Hicken, Dean Russell Kahn, Ellen Laird +7 more |
2023-04-25 |
|
| 11414404 |
Compounds for the treatment of BRAF-associated diseases and disorders |
Patrick Barbour, Katie Keaton BROWN, Erik James Hicken, Dean Russell Kahn, Ellen Laird +7 more |
2022-08-16 |
|
| 11247990 |
Bicyclic fused pyridine compounds as inhibitors of TAM kinases |
Shelley Allen, Mark Laurence Boys, John Gaudino, Ronald Jay Hinklin, Ellen Laird +4 more |
2022-02-15 |
|
| 11104676 |
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases |
Ronald Jay Hinklin, Shelley Allen, Patrick Barbour, Joshua Ryan Dahlke, John Gaudino +3 more |
2021-08-31 |
|
| 11098064 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2021-08-24 |
|
| 10953005 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Julia Haas +9 more |
2021-03-23 |
|
| 10881652 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more |
2021-01-05 |
|
| 10766881 |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases |
Steven W. Andrews, James F. Blake, Indrani W. Gunawardana, Kevin W. Hunt, Andrew T. Metcalf +3 more |
2020-09-08 |
|
| 10745419 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2020-08-18 |
|
| 10689377 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +7 more |
2020-06-23 |
|
| 10555944 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Julia Haas +9 more |
2020-02-11 |
$289,171,000 |
| 10441581 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more |
2019-10-15 |
|
| 10208024 |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases |
Steven W. Andrews, James F. Blake, Indrani W. Gunawardana, Kevin W. Hunt, Andrew T. Metcalf +3 more |
2019-02-19 |
$53,065,000 |
| 10172851 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Julia Haas +9 more |
2019-01-08 |
$9,244,000 |
| 10172845 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more |
2019-01-08 |
$9,244,000 |
| 10154995 |
Serine/threonine kinase inhibitors |
James F. Blake, Indrani W. Gunawardana, Kevin W. Hunt, Michael Lyon, Andrew T. Metcalf +10 more |
2018-12-18 |
$38,366,000 |
| 10144734 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more |
2018-12-04 |
$21,552,000 |
| 10137124 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Julia Haas +9 more |
2018-11-27 |
$19,902,000 |
